CGC Financial Services’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.28K Hold
93
﹤0.01% 238
2026
Q1
$8.06K Sell
93
-381
-80% -$36.5K ﹤0.01% 227
2025
Q4
$45.5K Hold
474
0.01% 137
2025
Q3
$45.1K Hold
474
0.01% 129
2025
Q2
$41.3K Hold
474
0.01% 130
2025
Q1
$42.6K Hold
474
0.02% 120
2024
Q4
$37.9K Hold
474
0.02% 123
2024
Q3
$42.7K Hold
474
0.02% 114
2024
Q2
$37.3K Hold
474
0.02% 120
2024
Q1
$41.3K Sell
474
-195
-29% -$16.6K 0.02% 110
2023
Q4
$55.1K Buy
669
+195
+41% +$14.9K 0.03% 103
2023
Q3
$37.1K Hold
474
0.03% 102
2023
Q2
$41.8K Buy
+474
New +$40.8K 0.03% 104

Other funds holding MDT

CGC Financial Services's MDT Position: Q2 2026 in Review

CGC Financial Services held its Medtronic (MDT) position steady in Q2 2026 at 93 shares worth $7.28K. The position accounts for ﹤0.01% of the portfolio, ranked #238.

CGC Financial Services first reported a position in MDT in Q2 2023 and has held it in 13 quarters since. The position peaked at $55.1K in Q4 2023. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • CGC Financial Services held 93 shares of Medtronic worth $7.28K as of Q2 2026.
  • CGC Financial Services left its Medtronic share count unchanged in Q2 2026.
  • Medtronic made up ﹤0.01% of CGC Financial Services's portfolio in Q2 2026, its #238 holding.
  • CGC Financial Services first reported a position in Medtronic in Q2 2023 and has held it in 13 quarters since.
  • CGC Financial Services's Medtronic position peaked at $55.1K in Q4 2023.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on CGC Financial Services's 13F filing for Q2 2026, filed 13 Jul 2026.